(Q33160108)

23 July 2017

title

The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events (English)

1 reference

23 July 2017

1 reference

H Almroth

1

1 reference

23 July 2017

T Andersson

2

1 reference

23 July 2017

E Fengsrud

3

1 reference

23 July 2017

L Friberg

4

1 reference

23 July 2017

P Linde

5

1 reference

23 July 2017

M Rosenqvist

6

1 reference

23 July 2017

A Englund

7

1 reference

23 July 2017

language of work or name

English

0 references

publication date

2 June 2011

1 reference

Journal of Internal Medicine

23 July 2017

published in

1 reference

23 July 2017

volume

270

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

281-290

1 reference

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

A biological approach to sudden cardiac death: structure, function and cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Atrial fibrillation: a risk factor for increased mortality--an AVID registry analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Rhythm control versus rate control for atrial fibrillation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PI

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02395.X

10.1111/J.1365-2796.2011.02395.X

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference